Pfizer PFE Biopharma — Revenues:

Similar metrics at other companies

FRPHDevelopment — Revenues:

$595K+98.3%

FRPHMultifamily — Revenues:

$5.44M-2.3%

SND

SNDSand Segment — Revenues:

$92.49M+43.5%

SND

SNDSmartSystems Segment — Revenues:

$623K-43.1%

SND

SNDCANADA — Revenues:

$17.11M+6,942%

SND

SNDSand — Revenues:

$92.49M+43.5%

FAQ

What is Pfizer's biopharma — revenues:?

Pfizer (PFE) reported biopharma — revenues: of $14.66B in Q2 2026.

How has Pfizer's biopharma — revenues: changed year-over-year?

Pfizer's biopharma — revenues: increased by 2.5% year-over-year, from $14.31B to $14.66B.

What is the long-term trend for Pfizer's biopharma — revenues:?

Over 4 years (2021 to 2025), Pfizer's biopharma — revenues: has grown at a -6.3% compound annual growth rate (CAGR), from $79.56B to $61.2B.

What does biopharma — revenues: mean?

The total gross income generated from the sale of pharmaceutical products, vaccines, and related services within the biopharma segment. It serves as the primary indicator of market demand and the commercial success of the segment's product portfolio.